PLEASE LOG IN TO ACCESS CLIENT-ONLY FEATURES.

USERNAME

PASSWORD

Type in the text displayed above

Remember Me

CREATE AN ACCOUNT FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

USERNAME OR EMAIL

AAH, WAIT, I REMEMBER NOW!

HC Research

LOGIN

COVERAGE
PUBLICATIONS
FEATURED
CALENDAR
ANALYSTS
ABOUT

Home
Blog
ESRS
ESRS EY 4Q17 review

23 January 2025

ESRS EY 4Q17 review

ESRS EY 4Q17 review

by Mariam Ramadan / Thursday, 29 March 2018 / Published in ESRS, Featured

PLEASE Log In TO ACCESS CLIENT-ONLY CONTENT.
Don't have an account? Sign Up

Tweet

About Mariam Ramadan

What you can read next

EFID EY reports 4Q17 net profit of EGP104m, beats estimate

PHD 1Q18 results review: lower y-o-y off-plan sales due to base effect, as expected

Heliopolis Housing (HELI EY)’s 1Q21/22 results

Recent Posts

TA ST daily & portfolio reports 21 January 2025

PLEASE Log In TO ACCESS CLIENT-ONLY CONTENT.Don...
MENA daily 20 January 2025

PLEASE Log In TO ACCESS CLIENT-ONLY CONTENT.Don...
TA ST daily & portfolio reports 20 January 2025

PLEASE Log In TO ACCESS CLIENT-ONLY CONTENT.Don...

Recent Comments

Archives

Categories

Meta

Log in
Entries feed
Comments feed
WordPress.org

The contents of this website, including any documents, tables, charts, visuals, images, and/or related download links, was issued by HC Brokerage, which is an affiliate of HC Securities & Investment (referred to herein as “HC”) – a full-fledged investment bank providing investment banking, asset management, securities brokerage, research, and custody services. The information used to produce this website and any affiliated documents or publications is based on sources that HC believes to be reliable and accurate. This information has not been independently verified and may be condensed or incomplete. HC does not make any guarantee, representation, or warranty and accepts no responsibility or liability for the accuracy and completeness of such information. Expression of opinion contained herein is based on certain assumptions and the use of specific financial techniques that reflect the personal opinion of the authors of the commentary and is subject to change without notice. The information in these materials reflects HC’s equity rating on a particular stock. HC, its affiliates, and/or their employees may publish or otherwise express other viewpoints or trading strategies that may conflict with the views included in this report. Please be aware that HC and/or its affiliates, and the investment funds and managed accounts they manage, may take positions contrary to the included equity rating. This material is for informational purposes only and is not an offer to sell or the solicitation of an offer to buy. Ratings and general guidance are not personal recommendations for any particular investor or client and do not take into account the financial, investment, or other objectives or needs of, and may not be suitable for, any particular investor or client. Investors and clients should consider this only a single factor in making their investment decision while taking into account the current market environment. Foreign currency denominated securities are subject to fluctuations in exchange rates, which could have an adverse effect on the value or price of, or income derived from, the investment. Investors in securities such as ADRs, the values of which are influenced by foreign currencies, effectively assume currency risk. Neither HC nor any officer or employee of HC accepts liability for any direct, indirect, or consequential damages or losses arising from any use of this report or its contents. HC is not a market maker in the securities of the subject company. HC, its affiliates, and/or directors and employees may own or have positions in and effect transactions of companies mentioned in this document. HC and its affiliates may also seek to perform or have performed investment banking services for companies mentioned in this memorandum. No part or excerpt of this website or any affiliated content may be redistributed, reproduced, or conveyed in any form, written or oral, to any third party without prior written consent of HC. By accessing this website, you have agreed to allow HC to monitor your activity only on this website after logging in with your account credentials. You may not share your login credentials to this website with any other party. The information within this website, including any internal and external hyperlinks, must not be disclosed to any other person until HC has made its information publicly available. By accessing this website, you have agreed to all terms and conditions, which are subject to change without notice. Failure to comply will result in termination of your login credentials and access to this website.

© 2015. All rights reserved. Buy Kallyas Theme.

TOP